Septerna (SEPN) Stock: Buy, Sell, or Hold?
SEPN - Septerna, Inc. Common Stock
$38.51
0.76 (2.01%)
▲
5d:
+4.65%
30d:
-20.09%
90d:
+13.16%
HOLD
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Aug 10, 2026
0d
Get Alerted When SEPN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SEPN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: SEPN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: SEPN is currently trading at $38.51, which is considered slightly low relative to its 30-day fair value range of $37.31 to $43.63.
Technical Outlook: Technically, SEPN is in a strong uptrend. Immediate support is located at $36.01, while resistance sits at $40.95.
Market Sentiment: SEPN scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $54.22 (+40.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SEPN is in a strong uptrend. Immediate support is located at $36.01, while resistance sits at $40.95.
Market Sentiment: SEPN scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $54.22 (+40.8%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$37.31 -
$43.63
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 40.8% below Wall St target ($54.22)
- CAUTION: Bottoming setup, but lagging the sector by 11% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$37.31 -
$43.63
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$36.01
Resistance Level
$40.95
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-19.84
Wall Street Target
$54.22
(+40.8%)
Revenue Growth (YoY)
22375.6%
Profit Margin
-24.5%
Share & Embed Analysis
Last updated: September 12, 2026 7:07 PM ET
Data refreshes hourly during market hours. Next update: 8:07 PM
Data refreshes hourly during market hours. Next update: 8:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SEPN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Elizabeth Bhatt
SELL
4000 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 48 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 54 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 44 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 53 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
